Cardiovascular Disease (CVD) Terminated Phase 2 Trials for Deferoxamine (DB00746)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00115349Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac DiseasesTreatment